Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Restoring may account for all lasting benefits of the tested

in surviving cells may explain all lasting benefits of the tested . Benefit from despite selectively blocked renewal, or failure of renewal alone with and their held near , would reject the claim.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionImpaired autophagy

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Candidate set selection
Goal
Перечень причинно самостоятельных идей серебряных пуль для продления жизни
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
10 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
8 / 10Few new entities
8 / 10Decisive experiment
8 / 10Silver-bullet potential
4 / 10Support from research
Poster: Mitophagy restoration explains lasting benefits
PosterOpen the sheet full size2026-10-01

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Rhythm or programme

    The delivery of to lysosomes and removal of whole

    Where this hypothesis actsSurviving , including and muscle fibres, during ageing

    Hypotheses on this target 3
    MitophagyInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 22Function preservation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation2
    • Function preservation
    • Feedback restoration
    • Rhythm restoration
    • Direct measurement

    What is proposed

    Activation

    Restore in surviving cells

    With whatControlled genetic model

    HowInducible genetic to switch off and restore it, with reporters to track the response

    Possible result

    Possible sustained functional benefits across multiple systems and increased lifespan

    From the recordВозврат митофагии восстанавливает пользу.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionMitophagy. Hypotheses on this target 3Mitophagy
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Several ways of slowing age-related decline could turn out to depend on the same repair process inside surviving cells. The unexpected move is to propose that even removing harmful cells works through the renewal of in nearby heart and muscle cells, triggered by the response that engulfs and clears removed cells. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Direct restoration of repairs the maintenance process in surviving heart and muscle cells.
  2. Removal of by immune cells is proposed to trigger an .
  3. That clearing response is proposed to activate in neighboring surviving heart and muscle cells.
  4. Reducing is also proposed to restore the same renewal process, although the intervening route is not specified.
  5. Restored is proposed to produce lasting benefits across several body systems and extend lifespan.
  6. Blocking , the selective breakdown and recycling of , is predicted to eliminate the lasting benefits of both indirect routes; restoring it is predicted to bring those benefits back.
A picture for it

Three switches might appear to power three different lights, while all three actually feed the same lamp. Disconnecting that lamp would make every switch ineffective.

Where the picture breaks: Cells do not have perfectly isolated wiring. Disabling could damage their ability to benefit from any intervention, so a shared loss of benefit would not by itself prove that every intervention works through the same route.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so acting on a shared cause could benefit several body systems at once.

    Rests on: The goal defines a potential route to life extension as a precise intervention on a cause shared by several aging processes.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    The desired result is a list of life-extension ideas that work through genuinely separate causes.

    Rests on: The master question requests ideas for on shared causes of aging; this stage specifies that the list should distinguish causally separate ideas.

    Stated in the chain
  3. Gap questionstep 03 of 04

    The number of distinct ideas would be determined by separately switching intermediate biological processes off and back on, then comparing lasting benefits across several body systems and effects on lifespan.

    Rests on: The preceding goal requires distinguishing ideas by their causes, but does not specify how that distinction should be measured.

    Assumption

    The work adopts the assumption that dependence on separately controlled intermediate processes, judged by lasting function and lifespan, provides the relevant way to count independent ideas.

  4. Hypothesisstep 04 of 04

    All three candidate are proposed to share one sufficient route: renewing in surviving cells. Lowering from , cells in a persistent state of stopped division, or removing those cells would provide lasting general benefits only by restoring that renewal. The proposed bridge from cell removal to renewal is the in the surrounding tissue.

    Rests on: The preceding question supplies the logic of switching intermediate processes off and restoring them. The endpoint fills that framework with the proposed dependence of all lasting benefits on .

    Assumption

    The central causal assumption is that is sufficient by itself and necessary for the lasting benefits of both other . The supplied material does not establish that dependence or the proposed bridge from to renewal in neighboring heart and muscle cells; these are the claims being proposed.

What is carried, and what is not. Individual links have partial support in other settings: S5, a 2026 review in Cells, reports that restoring mitochondrial function or maintenance can improve connective-tissue-supporting cells, but does not test the proposed or lasting whole-body benefits; S6, published in Aging Cell in 2026, reports that blocking mitochondrial recycling abolished protection in ultraviolet-exposed skin models, but does not establish the proposed route in heart or muscle. No supplied source establishes the full sequence or its exclusivity: S2, published in Nature Medicine in 2016, explicitly leaves other contributions to lifespan extension open, although that does not itself disprove this hypothesis.S5S6S2

Where the reasoning is carried by something unstated · 2
  • Gap question. The work adopts the assumption that dependence on separately controlled intermediate processes, judged by lasting function and lifespan, provides the relevant way to count independent ideas.
  • Hypothesis. The central causal assumption is that is sufficient by itself and necessary for the lasting benefits of both other . The supplied material does not establish that dependence or the proposed bridge from to renewal in neighboring heart and muscle cells; these are the claims being proposed.
How a result here could mislead · 3
  • Loss of benefit after blocking mitochondrial recycling could reflect injury to surviving cells rather than removal of the process through which the treatments work. Calling the block mild does not establish that it is harmless. What closes it: The same block must be assessed without the beneficial , alongside cell health and tissue function. Its restriction to the intended surviving cells, its effect on recycling, and recovery after restoration must be verified.
  • Apparent benefit from alone could still depend on an unnoticed decrease in harmful cells or their . Conversely, failure could arise from damage caused by the method used to keep those quantities at their starting levels. What closes it: Both cell numbers and must be followed throughout the relevant period, with acceptable departures from starting levels fixed in advance. Controls must establish the effects of the maintenance procedure itself; the supplied design acknowledges this requirement but does not specify how to meet it.
  • Dependence of cell-removal benefits on mitochondrial recycling could be mistaken for evidence that the is what triggers renewal in neighboring cells. Those are separate causal claims. What closes it: Testing that bridge requires distinguishing completed cell removal from the subsequent clearing response, and measuring renewal in the proposed neighboring cells. A way to separate those events is not supplied.

What would make this wrong. The central claim would be contradicted if reducing or removing retained lasting functional and lifespan benefits despite verified, appropriately restricted suppression of mitochondrial recycling without disabling injury. It would also be contradicted if verified restoration of alone failed to provide those benefits while harmful-cell numbers and remained near their starting levels under a maintenance procedure shown not to cause the failure.

What it would change. If the predicted pattern held, the tested candidates would represent one sufficient life-extension idea, and their apparent diversity would not justify counting them as independent solutions. Work on the master question would then have to distinguish genuinely separate causes from different ways of restoring the same process. Even that result would apply only to the tested candidates and conditions; the input specifies no endpoint species, follow-up duration, or complete intervention methods, and would not establish a universal solution to aging.

Sources read · 9

3 literature searches, 9 full texts, 1 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Background

The Gut-Brain-Muscle Axis: Microbial Regulation of Neuromuscular Aging and Cognitive Frailty. · Microorganisms · 2026

“We further discuss the role of exercise-induced microbiota remodeling and muscle endocrine signaling in promoting mitochondrial biogenesis and cognitive resilience.”

Does not settle: Источник не проверяет иммунное удаление клеток, фагоцитарный ответ, кардиомиоциты, минимальный достаточный набор {M} или утверждение, что восстановление митохондриального обновления объясняет все длительные эффекты R и C.

S2Contradicts it

Cardioprotection and lifespan extension by the natural polyamine spermidine. · Nature medicine · 2016

“Other protective effects of spermidine (including anti-tumorigenic effects ) may also contribute to its lifespan-extending effects, although we did not detect a reduced cancer incidence in aged spermidine-treated C57BL/6 mice,”

Does not settle: The source does not establish that mitochondrial renewal is the sole durable-benefit mechanism, that immune clearance causes mitochondrial renewal in neighboring cardiomyocytes or muscle fibers, or that reducing inflammatory secretion and senescent-cell number is insufficient.

S4Background

Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia. · International journal of molecular sciences · 2022

“The mammalian target of rapamycin (mTOR) is a major regulator of skeletal myocyte viability.”

Does not settle: This review excerpt does not establish that restoring mitochondrial renewal accounts for lasting benefits of any tested interventions, that it is a minimal sufficient intervention, or that immune clearance triggers mitochondrial renewal in neighboring cardiomyocytes or muscle fibers.

S5Partly answers it

Mitochondria-Lysosome Quality Flux in Aging Mesenchymal Stem/Stromal Cells: Quality-Control Bottlenecks and Therapeutic Opportunities for Regenerative Decline. · 2026

“Recent intervention studies further suggest that restoring mitochondrial metabolism or mitochondrial homeostasis can improve MSC function and attenuate senescence-associated phenotypes, including through the regulation of glutamine metabolism, the enhancement of mitochondrial biogenesis and the induction of mitophagy”

Does not settle: This review does not test the proposed M, R or C interventions, immune removal of cells, phagocyte-triggered mitochondrial renewal in neighboring cardiomyocytes or muscle fibers, durable whole-organism benefits, or whether mitochondrial renewal is necessary and sufficient for all benefits.

S6Partly answers it

The Secretome Derived From Human Umbilical Cord Mesenchymal Stem Cells Improves Skin Photoaging by Enhancing Mitophagy to Inhibit the cGAS-STING Pathway. · Aging cell · 2026

“Importantly, these protective effects were abolished by the mitophagy inhibitor Mdivi‐1, whereas the STING inhibitor H151 effectively reversed the Mdivi‐1‐induced loss of protection, confirming that SCT acts through the hierarchical mitophagy–cGAS‐STING axis.”

Does not settle: This source studies hUC-MSC secretome treatment in UV-exposed mice and UVB-irradiated human keratinocytes. It does not test immune clearance of senescent cells, phagocyte-triggered mitochondrial renewal in cardiomyocytes or muscle fibers, the proposed R/C interventions, lasting general benefits, or whether mitophagy alone is a minimal sufficient intervention.

S7Partly answers it

Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A. · Nutrients · 2026

“Both 500 mg and 1000 mg doses significantly modulated plasma acylcarnitine profiles and induced mitochondrial gene expression in skeletal muscle biopsies, providing the first human evidence of target engagement (mitophagy pathway activation) following oral UA consumption [ ].”

Does not settle: This review does not establish that mitochondrial renewal accounts for all lasting benefits of the tested interventions, that it is the minimal sufficient intervention, or that immune clearance triggers mitochondrial renewal in neighboring cardiomyocytes or muscle fibers. It also does not test the proposed causal roles of R and C or whether reduced inflammatory secretion and senescent-cell number are insufficient on their own.

S8Partly answers it

Mechanical loading primes MSC-derived exosomes to promote cartilage repair. · Bioactive materials · 2026

“Mechanistically, miR-330-3p restores mitochondrial quality control in chondrocytes by engaging an FKBP4-FoxO3a-dependent mitophagy program, leading to activation of PINK1/Parkin-mediated mitochondrial clearance.”

Does not settle: Источник описывает восстановление контроля качества митохондрий в хондроцитах и восстановление хряща в модели дефекта хряща у крыс. Он не устанавливает, что это объясняет все длительные эффекты вмешательств, не сравнивает наборы {M}, {R} и {C}, не изучает удаление сенесцентных клеток, фагоцитарный ответ, кардиомиоциты или мышечные волокна.

S9Partly answers itAbstract only

Juyuanjian attenuates sarcopenia through dual regulation of the Akt/FoxO1 and SIRT1/PGC-1α pathways. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026

“it also upregulated the expression of SIRT1 and PGC-1α, promoting mitochondrial biogenesis and adenosine triphosphate (ATP) production.”

Does not settle: The abstract does not establish mitochondrial renewal as the sole cause of lasting benefit, a minimal sufficient intervention, or a causal role for senescent-cell removal, phagocytic responses, neighboring cardiomyocytes, or muscle fibers. It reports JYJ effects in C. elegans, C2C12 cells, and SAMP8 mice, alongside effects on protein degradation and inflammation.

S10Partly answers itQuote unverified

Human umbilical cord-derived mesenchymal stromal cells ameliorate aging-associated skeletal muscle atrophy and dysfunction by modulating apoptosis and mitochondrial damage in SAMP10 mice. · Stem cell research & therapy · 2022

“Our results suggest that UC-MSCs can improve sarcopenia-related skeletal muscle atrophy and dysfunction via anti-apoptosis, anti-inflammatory, and mitochondrial biogenesis mechanisms that might be mediated by an AMPK-PGC1-α axis.”

Does not settle: Источник описывает лечение UC-MSC у мышей SAMP10 и не устанавливает, что восстановление митохондриального обновления является единственной причиной длительной общей пользы. Он не проверяет минимальный набор {M}, роли R и C, иммунное удаление клеток, фагоцитарный запуск обновления в соседних кардиомиоцитах или мышечных волокнах, а также недостаточность снижения воспалительной секреции и числа сенесцентных клеток.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

How many distinct ways of extending life remain when targets are tested by disabling and restoring shared biological steps?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сколько причинно самостоятельных идей «серебряных пуль» содержит проверяемый набор , если раздельное выключение и восстановление должно определить, какие остаются различимыми по длительной пользе нескольким системам и продолжительности жизни?

What this question is asking

The question concerns how many genuinely separate routes to longer life are represented by a collection of biological targets. It asks whether switching off and then restoring mediators—the biological steps through which an intervention produces its effects—can distinguish by their lasting benefits across several body systems and their effects on lifespan. would be compared over the same long observation period, and renaming an intervention or combining equivalent descriptions would not change the count. The question assumes that these dependency tests can support such a count, while allowing that shared mediators and limits on the benefit available may make different look equivalent. The supplied material does not identify the complete target collection or specify that common observation period.

What the terms mean
Biological target
A component or process that an intervention is intended to change. Different target names do not by themselves establish different routes to a benefit.
Intervention
A deliberate change, such as exercise, altered food intake, or disabling a gene, whose effects are assessed. Here, are compared by their biological dependencies and lasting outcomes.
Mediator and biological dependency
A mediator is an intermediate biological step through which an intervention affects an outcome. An outcome depends on that step when disrupting it prevents the relevant effect in the tested setting; this does not establish that the step alone can produce the effect.
Disabling and restoration
Disabling reduces or removes a biological component's activity; restoration brings that component or its activity back. The question uses these changes to examine which effects depend on which steps.
Causally independent routes and causal equivalence
These describe whether work through distinguishable chains of biological effects or can be grouped as the same route under a stated rule. They are proposed categories for counting, and the supplied material does not provide a complete rule for assigning them.
Ceiling on benefit
A limit beyond which a measured benefit no longer increases. Such a limit could make different look similar, but its role in the intended target collection is not established.
Muscle stem cells and activation
Muscle stem cells are cells involved in maintaining and repairing muscle. Activation is their transition from a resting state toward activity involved in repair; S5 concerns their ability to make that transition in old mice.
Cyclin D1
A protein involved in controlling a cell's progression toward division. S5 identifies its restoration as necessary for recovery of the muscle stem-cell activation ability described there.
Genes and genetically altered model
Genes are inherited instructions that influence biological functions. A genetically altered model is an organism with an inherited change used to study a process; S6 concerns a particular worm model rather than all forms of reduced food intake.
Autophagy
A group of processes through which cells break down and recycle their own material. S6 concerns the requirement for this activity in the intestine in one worm lifespan model.
Dietary restriction
Reduced food intake or availability relative to a comparison condition. It covers different experimental arrangements; S6 concerns one genetic model of it.
Insulin sensitivity
How strongly the body responds to insulin, a hormone that helps regulate blood sugar. S8 measures changes in this response rather than lifespan.
Oxygen-dependent metabolism
The chemical processes through which cells use oxygen to help obtain energy. S8 reports indicators of these processes, which are measurements of selected features rather than a complete account of how the work.
Littermates
Animals born in the same litter. The supplied S7 excerpt uses such animals as the comparison for mice lacking the candidate target.
What the question takes for granted
Premise only partly supported
Separate disabling and restoration of mediators can determine which remain causally distinguishable by long-term benefits across several systems and lifespan, allowing a count that is unchanged by renaming or combining equivalent descriptions.

A mediator is a biological step between an intervention and its effects; disabling it tests whether an effect depends on that step, while restoring it examines whether the effect returns. The question assumes that these tests can sort a collection of into genuinely different ways of producing lasting benefits and longer life. If that assumption holds, the count would reflect biological differences rather than the number of labels attached to targets.

S5 reports that recovery of activation ability in old mouse muscle stem cells depends on restoration of Cyclin D1. S6 reports that inhibiting cellular recycling in the intestine prevents the long lifespan of a particular worm model of restricted food intake. These support narrower claims about dependence on particular biological steps. Neither establishes a method for counting independent routes across a complete target collection using both disabling and restoration, a shared long-term comparison, benefits across several systems, and lifespan.S5S6

The same question asked without the part nothing read establishes:

  • Which in the target collection remain distinguishable in lasting benefits across several body systems and lifespan after shared biological steps are disabled and restored?
  • What do the read sources establish about whether the candidate depend on the same biological steps for their benefits?
What turns on the answer
  • Several targets reduce to fewer routes If the dependency tests showed that differently named produced their lasting benefits through the same route, those names would not establish separate opportunities to extend life. Treating every target as independent would then overcount the possibilities under the question's proposed counting rule.
  • Several routes remain distinguishable If retained different dependencies and different lasting effects after the tests, combining their descriptions would conceal biological differences. Under the question's proposed rule, those distinguishable routes would count separately.
  • The tests leave the count unresolved If shared steps or a ceiling on measurable benefit made different routes produce indistinguishable results, the tests would not uniquely determine the count. An apparent match in outcomes would then leave open whether the were equivalent or whether the comparison could not distinguish them.
Why it matters

An intervention may affect a target, which changes a mediator, which then changes how a body system functions. If several depend on the same mediator, counting their names separately could overstate the number of independent opportunities to extend life. Conversely, similar measured benefits do not establish that the work through the same route. Mistaking short-term improvement in one tissue for lasting benefits across several systems would also assign an intervention a broader effect than the supplied findings establish.

What is already established

S-узлы описывают клеточные и иммунные механизмы уровней RL-1 и RL-2; метод проверки зависимостей доступен, не подсчитаны.

What would have to be true

Число самостоятельных идей, устойчивое к переименованию и объединению эквивалентных описаний, с различимыми прогнозами на общем .

What is missing

Число названных неизвестным образом соотносится с числом самостоятельных возможностей продления жизни; общие и могут скрывать различия.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

В наборе содержится одна самостоятельная идея: восстановление в сохраняющихся клетках. состоит из одного элемента {}; дают длительную общую пользу лишь постольку, поскольку вторично восстанавливают этот же процесс. Предполагается, что после запускает в соседних и . Уменьшение и само по себе недостаточно. сохраняет исходную . кандидатов имеет вид {{,,}}, а имеет вид {}.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При подтверждённом и снижении их мягкое выключение только в сохраняющихся полностью устраняет длительную пользу . Возврат восстанавливает пользу. Напротив, изолированное сохраняет функциональный и жизненный выигрыш при экспериментальном удержании и их около . Такой результат отличает {} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.

Would tell it apart from at least one rival. The prediction specifies loss, restoration, and preservation of benefits under stated conditions, providing measurable qualitative outcomes. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

и позволяют проверить ближайшую причинную зависимость. Проверка при сохранении исходной значительно сложнее: потребуется контролировать несколько факторов, а также исключить повреждение от самого способа их поддержания.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При подтверждённом и снижении их мягкое выключение только в сохраняющихся полностью устраняет длительную пользу . Возврат восстанавливает пользу. Напротив, изолированное сохраняет функциональный и жизненный выигрыш при экспериментальном удержании и их около . Такой результат отличает {} от двух независимых элементов, трёх независимых элементов и обязательной комбинации.

  • What would separate them

    Organelle renewal and senescent cell clearance may provide independent lasting benefits predicts: После выравнивания завершённого перестаёт давать дополнительный длительный эффект. сохраняет пользу при умеренном специфическом снижении ; сохраняет пользу при снижении . Возврат соответствующего восстанавливает только его ветвь. переработки материала показывает два независимо изменяемых . В отличие от гипотезы 01, способен приносить пользу при ограниченном ; в отличие от гипотезы 03, не сохраняет отдельного эффекта при фиксированном ; в отличие от гипотезы 04, одиночные и проходят общий .

  • What would separate them

    Organelle upkeep, secretion control and cell removal may independently extend life predicts: Каждое одиночное проходит общий и сохраняет часть пользы при специфическом ограничении двух других процессов. Для подавление устраняет и длительный эффект; возврат восстанавливает оба результата. и сохраняют пользу в тех же условиях. Особенно различающий результат: улучшает функции и при экспериментально фиксированных и .

  • What would separate them

    Mitochondrial upkeep and senescent cell removal may jointly be required for longer life predicts: Из семи активных сочетаний общий проходят только + и ++; добавление к + не улучшает результат сверх заранее заданной . Ни , ни по отдельности не достигают даже при подтверждённом и при нескольких допустимых уровнях интенсивности. Специфическое выключение любого из двух процессов в успешной комбинации устраняет общий выигрыш, а его возврат восстанавливает выигрыш. , ожидаемая в гипотезе 01, или , ожидаемая в гипотезах 02 и 03, опровергает этот набор.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

Парадоксальная опора: обслуживание частично выполняют соседние . Это показывает, что клеточная граница и граница обслуживающего процесса различаются, но не доказывает предложенную универсальную зависимость. [Nicolás-Ávila и соавт., Cell, 2020](https://pubmed.ncbi.nlm.nih.gov/32937105/). В клеточной работе восстановление базальной обращало ряд признаков старения. [Исследование базальной , 2024](https://pubmed.ncbi.nlm.nih.gov/38897197/).

Subfield revised

; пересмотру подлежал бы учебный раздел « и причинная роль накопления ». Сильное утверждение состоит в том, что весь длительный общий выигрыш исследуемых определяется сохраняющихся клеток.

Testable surprise

Сохранение высокой сенесцентной нагрузки и совместимо с полным выигрышем , тогда как эффективное теряет весь длительный выигрыш при избирательном нарушении соседних клеток.

Why this is not the mainstream account

Строго доказать отсутствие такой позиции во всей литературе невозможно. В выполненном целевом поиске не найден обзор, утверждающий именно полную зависимость многосистемной и жизненной пользы , от сохраняющихся клеток. Известные обзоры связи и этой сильной версии не устанавливают. Статус роли HERETICAL остаётся предварительным.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.